# Syndax Pharmaceuticals Inc: Form 8-K, filed May 26, 2023

- Company: [Syndax Pharmaceuticals Inc](/companies/sndx.md) (CIK 1395937)
- Form: 8-K
- Filed: 2023-05-26
- Accepted by EDGAR: May 26, 2023, 16:47 ET
- Period: 2023-05-26
- Accession: 0000950170-23-024544
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1395937/000095017023024544/sndx-20230526.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1395937/000095017023024544/

## Items reported

- Item 1.02: Termination of a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1395937/000095017023024544/sndx-20230526.htm

Filed May 26, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-024544. Last ingested by Listed: Nov 2, 2026, 16:31 ET. No prices; not investment advice.